日韩中文字幕永久免费观看电剧_亚洲国产中文av网站1区_这里只有精品无卡顿_黄色影院在线观看视频_先锋音影亚洲自拍_熟妇高潮一区二区精品色欲_欧美巨大粗爽av在线观看_九九中文字幕天堂女人_亚洲国产日韩欧美综合久久_真实国产老熟女粗口
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2024.01.31
海普瑞:關(guān)于2023年度擬計(jì)提存貨跌價(jià)準(zhǔn)備的提示性公告
2024.01.31
海普瑞:2023年年度業(yè)績(jī)預(yù)告
2024.01.16
海普瑞:關(guān)于收到深圳證監(jiān)局監(jiān)管關(guān)注函的公告
2024.01.15
海普瑞:關(guān)于子公司重要事項(xiàng)的公告
2024.01.10
海普瑞:2024年第一次臨時(shí)股東大會(huì)決議公告
2023.12.19
海普瑞:關(guān)于聯(lián)營(yíng)公司君圣泰醫(yī)藥擬在香港聯(lián)交所主板上市的公告
2023.12.18
海普瑞:關(guān)于召開(kāi)2024年第一次臨時(shí)股東大會(huì)的通知公告
2023.12.18
海普瑞:關(guān)于修訂《公司章程》等相關(guān)制度的公告
2023.12.18
海普瑞:第六屆董事會(huì)第六次會(huì)議決議公告
2023.12.18
海普瑞:2023年第一次臨時(shí)股東大會(huì)、2023年第一次A股類別股東會(huì)議及第一次H股類別股東會(huì)...
第一頁(yè)
上一頁(yè)
6
7
8
9
10
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.